Index of reports
> Cases with Respiratory Distress (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sabril (Vigabatrin) where reactions include respiratory distress. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Sabril side effects in 9 year old male
Reported by a physician from United States on 2012-08-06
Patient: 9 year old male
Reactions: Pneumonia, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sabril
Other drugs received by patient: Zonisamide; Baclofen
Possible Sabril side effects in 2 year old male
Reported by a consumer/non-health professional from United States on 2012-05-29
Patient: 2 year old male
Reactions: Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sabril
Dosage: 750 mg milligram(s), 2 in 1 d, oral
Administration route: Oral
Indication: Grand MAL Convulsion
Start date: 2011-03-24
Sabril
Dosage: 750 mg milligram(s), 2 in 1 d, oral
Administration route: Oral
Indication: Infantile Spasms
Start date: 2011-03-24
Possible Sabril side effects in 16 month old female
Reported by a physician from United States on 2012-04-05
Patient: 16 month old female
Reactions: Urinary Tract Infection Bacterial, Respiratory Distress, Enterobacter Test Positive, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sabril
Dosage: 250 mg milligram(s), am; 500 mg milligram(s), pm
Indication: Infantile Spasms
Start date: 2011-08-18
End date: 2012-03-01
Sabril
Dosage: 250 mg milligram(s), am; 500 mg milligram(s), pm
Indication: Infantile Spasms
Start date: 2012-03-01
Sabril
Dosage: 250 mg milligram(s), am; 500 mg milligram(s), pm
Indication: Infantile Spasms
Start date: 2012-03-01
Possible Sabril side effects in 8 month old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21
Patient: 8 month old female
Reactions: Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sabril
Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
Administration route: Oral
Indication: Infantile Spasms
Start date: 2011-11-25
End date: 2011-12-19
Sabril
Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
Administration route: Oral
Indication: Convulsion
Start date: 2011-11-25
End date: 2011-12-19
Sabril
Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
Administration route: Oral
Indication: Infantile Spasms
Start date: 2011-12-20
Sabril
Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
Administration route: Oral
Indication: Convulsion
Start date: 2011-12-20
Other drugs received by patient: Klonopin; Topamax; Keppra
Possible Sabril side effects in 1 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-09
Patient: 1 year old male
Reactions: Malaise, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sabril
Possible Sabril side effects in 14 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-13
Patient: 14 year old female
Reactions: Urinary Tract Infection, Condition Aggravated, Complex Partial Seizures, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sabril
Other drugs received by patient: Keppra; Topamax; Phenobarbital TAB
|